Difficulty: Medium
Average Score: 68%
Practice
A postmenopausal woman is administered estradiol (Estraderm). What condition will be prevented in this patient?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Osteoporosis. Estradiol is a form of estrogen, and in postmenopausal women, estrogen levels decline, leading to an increased risk of osteoporosis. Estrogen plays a crucial role in maintaining bone density by inhibiting bone resorption. By administering estradiol to the postmenopausal woman, the healthcare provider aims to prevent or slow down the progression of osteoporosis.
Option A) Endometriosis is incorrect because estradiol would not prevent this condition. Endometriosis is a gynecological disorder characterized by the growth of endometrial tissue outside the uterus, and estradiol could potentially exacerbate this condition.
Option B) Amenorrhea is incorrect as estradiol would not prevent the absence of menstrual periods. Amenorrhea can have various causes, and estradiol is not a treatment specifically for this condition.
Option D) Uterine cancer is incorrect because estradiol, especially when used without a progestin component, can actually increase the risk of uterine (endometrial) cancer in postmenopausal women. Estrogen-only therapy is contraindicated in women with an intact uterus due to this increased risk.
Educationally, understanding the role of hormones like estrogen in maintaining bone health and the potential risks and benefits of hormone replacement therapy in postmenopausal women is crucial for healthcare providers. It highlights the importance of individualized treatment plans based on the patient's specific needs and risks.
Option A) Endometriosis is incorrect because estradiol would not prevent this condition. Endometriosis is a gynecological disorder characterized by the growth of endometrial tissue outside the uterus, and estradiol could potentially exacerbate this condition.
Option B) Amenorrhea is incorrect as estradiol would not prevent the absence of menstrual periods. Amenorrhea can have various causes, and estradiol is not a treatment specifically for this condition.
Option D) Uterine cancer is incorrect because estradiol, especially when used without a progestin component, can actually increase the risk of uterine (endometrial) cancer in postmenopausal women. Estrogen-only therapy is contraindicated in women with an intact uterus due to this increased risk.
Educationally, understanding the role of hormones like estrogen in maintaining bone health and the potential risks and benefits of hormone replacement therapy in postmenopausal women is crucial for healthcare providers. It highlights the importance of individualized treatment plans based on the patient's specific needs and risks.